- UID
- 70927
- 精华
- 积分
- 40038
- 胶币
- 个
- 胶分
- 点
- 技术指数
- 点
- 阅读权限
- 150
- 在线时间
- 小时
- 注册时间
- 2011-12-14
- 最后登录
- 1970-1-1
|
马上注册,结交更多胶友,享用更多功能!
您需要 登录 才可以下载或查看,没有账号?注册
×
Friday, September 21, 2012
+ W- B+ j4 v% M- h1 m0 f. e. s& B ?7 d" o; G' ]
Natick, MA - Boston Scientific has signed a definitive agreement to acquire BridgePoint Medical, Inc., a privately held company based in Minneapolis, MN. BridgePoint Medical has developed a proprietary, catheter-based system to treat coronary chronic total occlusions (CTOs). The transaction is expected to close in the fourth quarter of 2012 subject to customary closing conditions. The transaction is expected to have an immaterial impact on GAAP and adjusted earnings in 2012 and 2013 and be modestly accretive thereafter. Financial terms of the transaction are not being disclosed. - |
|